• Tidak ada hasil yang ditemukan

pics seminar series 2 delivery material finaldraft

N/A
N/A
Protected

Academic year: 2017

Membagikan "pics seminar series 2 delivery material finaldraft"

Copied!
69
0
0

Teks penuh

(1)

Six Sessions

Get You Better at PIC/S GMP

Session 2

(2)

8:30 – 10:00

Registration

10:00 – 10:15

Opening Session by GP Farmasi

10:15 – 11:45

Materials Presentation

11:45 – 12:00

Break

12:00 – 12:50

Q & A

12:50 – 13:05

Quiz

13:05 – 13:20

Explanation of Quiz Answer

13:20

Closing Session

(3)

◎Presenter

Dr.GTakahashiG(Q&A)G Mr.GTahara Ms.GLanny

(4)

Agenda

Session 1. Introduction & GMP Guide Part I (Chapter 1 & 2)

Session 2. PIC/S GMP Guide –Part I (Chapter 3 & 4)

Session 3. PIC/S GMP Guide –Part I (Chapter 5 & 6)

Session 4. PIC/S GMP Guide –Part I (Chapter 7 to 9) and Basic of Site Master File

Session 5. PIC/S GMP Guide –Annex 1 Manufacture of Sterile Medicinal Products

Session 6. PIC/S GMP Guide –Annex 15 Qualification and Validation

(5)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Todayʼs Topics

1. A Quick Recap of Our Previous

Session

2. PIC/S Part I - Chapter 3

Premises and Equipment

(6)

1.G

A Quick Recap of Our Previous Session

Commenced operating on 2 Nov. 1995

History of PIC/S

http:// .pi s he e.o g/

Numbers on PIC/S

48 Members in the world

7 Members in Asia (Singapore, Malaysia, Indonesia,

Taiwan, Japan, Korea, Hong Kong)

4 Partner Organizations

(7)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

1. A Quick Recap of Our Previous Session

EU legal enforcement system

Regulation The most significant

enforcement. Directly applied in preference to national law in EU Member States.

Directive The applicable enforcement by sector. It must be replaced to national law amended or enacted within 3 years.

Decision Directly binding while just targeting some specific requirements in a more detail manner.

Recommendation Not legally binding, but it encourages EU Member States to amend or enact the legislation.

Opinion To express the current thinking the EU Commission in a particular theme.

PIC/S GMP PIC/S

(8)

1. A Quick Recap of Our Previous Session

Mutual Recognition Arrangement (MRA)

MRA MRA

(9)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

1. A Quick Recap of Our Previous Session

PIC/S GMP GUIDE PART I:

BASIC REQUIREMENTS FOR MEDICINAL PRODUCTS

Chapters

Part I

Chapte   Chapte   Chapte  

  Chapte   Chapte   Chapte   Chapte   Chapte   Chapte  

1.QMS

2. Personnel

3. Premises/equipment 4. Documentation

5. Production 6. QC

7. CMO

(10)

1. A Quick Recap of Our Previous Session

Regulatory Compliance

T a a a a a y a a

, a a a a .

PIC/S GMP has been becoming a global standard

(11)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

1. A Quick Recap of Our Previous Session

Quality Management System (QMS)

= Quality System = Quality Assurance

Recap of Chapter 1: Quality Management

QMS

Continuous improvement throughout the life cycle

GMP

Quality assurance in

day-to-day production activities

Quality

(12)

1. A Quick Recap of Our Previous Session

GMP QC

PQR

Ma k

Pete

Tho as Bill

Mi hael 

Ri ha d

QRM

PQR

To ensure that the medicinal products produced are;

fit for their intended use,

comply with the requirements of the market authorization,

do not place patients at risk

due to inadequate safety, quality or efficacy.

(13)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

1. A Quick Recap of Our Previous Session

Method

Recap of Chapter 2: Personnel

a  ade uate  u e

of pe so el  & p a ti al e pe ie ee essa   ualifi atio s  itte  jo  des iptio s 

Ma k

Pete

Tho as Bill

Mi hael 

Ri ha d

(14)

1. A Quick Recap of Our Previous Session

QA relies upon correct manufacture (4Ms), which rely upon

people .

Principle

Pe so el

P o ess

Validatio

Sa pli g

Re o d Release

(15)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Todayʼs Topics

1. A Quick Recap of Our Previous

Session

2. PIC/S Part I - Chapter 3

Premises and Equipment

(16)

2. Chapter 3: Premises and Equipment

Premises and equipment must be located, designed,

constructed, adapted and maintained to suit the operations to be carried out.

The layout and design must aim to minimize the risk of errors and permit effective cleaning and maintenance in order to avoid cross-contamination, build up of dust/dirt and any adverse effect on the quality of products.

Itʼs about design + engineering

Hi

Pharmaceutical industry

provides unique

challenges No

 o specify criteria or numerical for premises and

equipment W

hs Your ingenuity will be

(17)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

PRINCIPLE

Premises and equipment must be located, designed, constructed, adapted and maintained to suit the operations to be carried out. Their layout and design must aim to minimize the risk of errors and permit effective cleaning and maintenance in order to avoid cross-contamination, build up of dust or dirt and, in general, any adverse effect on the quality of products.

Premises should be carefully maintained, ensuring that repair and maintenance operations do not present any hazard to the quality of products. They should be cleaned and, where applicable, disinfected according to detailed written

procedures.

.

2. Chapter 3: Premises and Equipment

(18)

2. Chapter 3: Premises and Equipment

A typical flowchart in facility project case:

Feasi ilit

Co eptual  de elop e t

P oje t 

pla i g Basi  desig  + DQ

Detailed  desig  +  Spe ifi atio

Supplie  

sele tio Co st u tio+ i stallatio

IQ/OP/PQ

P odu tio  +  ai te a e

(19)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Risk Co t ol

*De easi g Risk  *Risk A epta e

Fish Bo e, FMEA et . UR

ISP

ia

PUR

*P odu t Qualit *CQA *CPP,GMP GUR

*P odu t Capa it Et .

Co eptual Desig

Risk Assess e t

*Spe if  Risk *Risk A al sis

SIA

*Risk Assess. Desig  Co ept Desig  data et .

URS PUR

*P odu t Qualit *CQA *CPP,GMP

GUR

*P odu t Capa it Et .

C iti al Aspe ts *Fa ilit /S ste Spe ifi atio

Basi  

Desig Detail Desig DQ *Self I spe tio

Co e ial

Qualifi atio  

Co issio i g

(20)

Choose proper clean class for each process

Example of Aseptic process ISPE Baseline Guide Vol.3, Jan 1999

G Grade Grade

Grade

Min.

Intervention FillingGProcessCleanGBench

NoG

Intervention Critical portionGfor sterile

Grade C

Garment FormulationG etc.

WashingGToolsGetc.

Machine room,GOut side.

Co t olled  ot  lassified

2. Chapter 3: Premises and Equipment

Clean Garment

(21)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

(22)

2. Chapter 3: Premises and Equipment

Whether a new or existing facility, clarify the concept first.

Be certain it can be explained by you.

What do you want the premises to do?

U

Mountains of

books QRM  app

oa

h Scientific evidences

Good qualification practice Knowledge managementUse of quality risk management (QRM) approach

Implementation of DQ/IQ/OQ/PQ

Make all records comprehensible to any personnel.

Turn your mountains of books into the best practice

(23)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

Situated in a suitable environment

Carefully maintained ensuring the cleanliness

Appropriate lighting, temperature, humidity and ventilation

Designed as to afford protection against the entry of insects

Steps taken to prevent the entry of unauthorized people

General requirements for premises

(24)

Lighting, temperature, humidity and ventilation should be appropriate and such that they do not adversely affect, directly or indirectly, either the medicinal

products during their manufacture and storage, or the accurate functioning of equipment.

Premises should be designed and equipped so as to afford maximum protection against the entry of insects or other animals.

.

2. Chapter 3: Premises and Equipment

General

(25)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

General

Steps should be taken in order to prevent the entry of unauthorized people,

Production, storage and quality control areas should not be used as a right of way be personnel who do not work in them.

.

CleanG Corridor

Process RoomGB Process

RoomGA Process

(26)

2. Chapter 3: Premises and Equipment

Dedicated and self-contained facilities for medical hazard

Zoning and layout

Flow of material and product to prevent mix-ups

Interior surfaces (walls, floors and ceilings) consideration

Good M/E work

Adequate size of drains

Effectively ventilated with air control facilities

Separated weighing room for starting materials

Specific provisions taken for where dust is generated

Packaging rooms to avoid mix-ups or cross-contamination

Adequate room brightness

In-process controls may be conditionally carried out within the production area

(27)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Production Area

In order to minimize the risk of a serious medical hazard due to

cross-contamination, dedicated and self-contained facilities must be available for the production of particular medicinal products, such as highly sensitizing materials (e.g. penicillins) or biological preparations(e.g. from live micro-organisms).

The production of certain additional products, such as certain antibiotics, certain hormones, certain cytotoxics, certain highly active drugs and non-medicinal

products should not be conducted in the same facilities. For those products, in exceptional cases, the principle of campaign working in the same facilities can be accepted provided that specific precautions are taken and the necessary validations are made. The manufacture of technical poisons, such as pesticides and herbicides, should not be allowed in premises used for the manufacture of medicinal products.

.

(28)

2. Chapter 3: Premises and Equipment

Dedicated and self-contained facilities for medical hazard

Highl  se sitizi g  ate ials

e.g. pe i illi  d ugs

Biologi al p epa atio s

e.g. li e  i o‐o ga is s

o tai e t

isolato

A epta le Dail  E posu e  ADE O upatio al E posu e Li its  OEL

(29)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

(30)

SegregationGofGHazardousGFactory

2. Chapter 3: Premises and Equipment

Air Lined Suit

(31)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Where starting and primary packaging materials, intermediate or bulk products are exposed to the environment, interior surfaces (walls, floors and ceilings) should be smooth, free from cracks and open joints, and should not shed particulate matter and should permit easy and effective cleaning and, if necessary, disinfection.

Pipe work, light fittings, ventilation points and other services should be designed and sited to avoid the creation of recesses which are difficult to clean. As far as possible, for maintenance purposes, they should be accessible from outside the manufacturing areas.

.

2. Chapter 3: Premises and Equipment

Production Area

.

Clean room

(32)

Drains should be of adequate size, and have trapped gullies. Open channels should be avoided where possible, but if necessary, they should be shallow to facilitate cleaning and disinfection.

.

2. Chapter 3: Premises and Equipment

Production Area

PIC/S GMP Annex 1

50. Sinks and drains should be prohibited in grade A/B areas used for aseptic

manufacture. In other areas air breaks should be fitted between the machine or sink and the drains. Floor drains in lower grade clean rooms should be fitted

with traps or water seals to prevent backflow.

Pure Steam

Air Brake

(33)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Productions areas should be well lit, particularly where visual on-line controls

are carried out.

.

2. Chapter 3: Premises and Equipment

Production Area

In cases where dust is generated (e.g. during sampling, weighing, mixing and processing operations, packaging of dry products), specific provisions should be taken to avoid cross-contamination and facilitate cleaning.

.

Premises for the packaging of medicinal products should be specifically designed and laid out so as to avoid mix-ups or cross-contamination.

.

FDA CGMP § 211.44 - Lighting.

(34)

2. Chapter 3: Premises and Equipment

Good M/E work

Adequate size of drains

Separated weighing room for starting materials

Avoid creation of recessesAccessible from outside

I depe de t u it

T apped d ai /slope Eas  to  lea

Stati  diffe e tial Ai flo

e haust

MAU

e haust

F esh ai

A essi le f o  outside

(35)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

Effectively ventilated with air control facilities

Ai flo patte

DB ℃ RH%

+ p essu e

HVAC a d

Mo ito i g

Mai te a e

Co t ol fa ilit

Clea li ess

A comprehensive system

(36)

2. Chapter 3: Premises and Equipment

Interior surface (wall, floor and ceiling) consideration

Smooth surfaces

Free from cracks/open joints

Permit easy and effective cleaning

Mate ials

 Co st u tio

 Co figu atio

• Co osio

• Peeli g • Diffi ult to  lea• Residual dete ge t

E

uip

e

t

(37)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

Specific provisions taken for where dust is generated

i di atio

Level 1

Spa e + i di atio

Level 2

Light pa titio

Level 3

Lo ked

Full isolatio Sepa ate HVAC

Level 5

Lo ked

Pa titio   all

Level 4 With  eili g Haza d t pe

(38)

2. Chapter 3: Premises and Equipment

Packaging rooms to avoid mix-ups or cross-contamination

P odu t B

Ca to   o es fo  B P i a  pa kage

P odu t A Ca to   o es fo  A

Se o da  pa kage

Sepa ated    pa titio s Sepa ated   

(39)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

In-process controls may be conditionally carried out within the production area

Adequate room brightness

Productions areas should be well lit, particularly where visual on-line controls are carried out.

Slightly different between cGMP and EU-GMP

e.g. on particle sizes:

5μm is not applicable.

both 0.5 & 5μm are applicable.

on continuing monitoring requirement

remote monitoring is not a mandate.

remote monitoring is not a mandate for Grade B area, but a mandate for Grade A.

The  a i u  allo a le pa ti les  u e /

At rest In operation Grade 0.5μm 5.0μm 0.5μm 5.0μm A (ISO 5) 3,520 20 3,520 20

B (ISO 7) 3,520 29 352,000 2,900

C (ISO 8) 352,000 2,900 3,520,000 29,000

D 3,520,000 29,000 - -

Reference: EU-GMP Glasses of air cleanliness (2008)

cGMP

EU GMP

cGMP

(40)

2. Chapter 3: Premises and Equipment

Sufficient capacity to meet various storage needs

Storage condition considerations (temperature, humidity)

Receiving/dispatch bays and receptions areas

Quarantine status considerations

A separate sampling area for starting materials

・・・・・・・

Storage area (Section 3.18 to 3.25)

QC      

La Ma ufa tu i g a ea

Wa ehouse

Re ei i g  a Dispat h  a

Qua a ti e Sa pli g 

(41)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Storage areas should be designed or adapted to ensure good storage

conditions. In particular, they should be clean and dry and maintained within

acceptable temperature limits. Where special storage conditions are required (e.g. temperature, humidity) these should be provided, checked and monitored.

2. Chapter 3: Premises and Equipment

.

There should normally be a separate sampling area for starting materials. If

sampling is performed in the storage area, it should be conducted in such a way as to prevent contamination or cross-contamination.

.

Storage Area

Printed packaging materials are considered critical to the conformity of the

medicinal products and special attention should be paid to the safe and secure storage of these materials.

(42)

2. Chapter 3: Premises and Equipment

Normally, QC lab should be separated from production area.

QC lab should have Sufficient space to avoid mix-ups and cross-contamination

Sensitive instruments need to be protected in separate

rooms from vibration, electrical interference, humidity, etc.

・・・・・・

Quality control area (Section 3.26 to 3.29)

QC      

La Ma ufa tu i g a ea Wa ehouse

Re ei i g  a Dispat h  a

Qua a ti e Sa pli g 

(43)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Normally, Quality Control laboratories should be separated from production

areas. This is particularly important for laboratories for the control of biologicals, microbiologicals and radioisotopes, which should also be separated from each other.

2. Chapter 3: Premises and Equipment

Quality Control Area

(44)

2. Chapter 3: Premises and Equipment

Rest and refreshment rooms should be separate from other areas.

Facilities for gowning, washing purposes to be easily accessible and appropriate for the number of users.

Maintenance workshops to be as far as possible separated from production areas.

Whenever parts/tools are stored in production area, to be kept in rooms or lockers reserved for that use.

・・・・・・・

(45)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

2. Chapter 3: Premises and Equipment

Facilities for changing clothes, and for washing and toilet purposes should be easily accessible and appropriate for the number of users. Toilets should not directly communicate with production or storage areas..

.

Ancillary Area

Example of Aseptic process ISPE Baseline Guide Vol.3, Jan 1999

G

Machine room,GOut side.

Co t olled  ot  lassified

Clean Garment No

(46)

2. Chapter 3: Premises and Equipment

Designed/located/maintained to suit its intended purpose.

Maintenance should not present hazard to product quality.

Equipment should be easily/thoroughly cleaned.

………

Measuring/control equipment should be calibrated and checked at defined intervals. Records of such tests should be maintained.

………

Requirements for equipment (Section 3.34 to 3.42)

P

Ope ati g  I st u tio

Re o d Data ase 

P og a

T

Co puti g Computerized system validation

(47)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Manufacturing equipment should be designed so that it can be easily and thoroughly cleaned. It should be cleaned according to detailed and written procedures and stored only in a clean and dry condition.

Washing and cleaning equipment should be chosen and used in order not to be a source of contamination.

.

2. Chapter 3: Premises and Equipment

.

Equipment

Measuring, weighing, recording and control equipment should be calibrated and checked at defined intervals by appropriate methods. Adequate records of such tests should be maintained.

.

Fixed pipework should be clearly labelled to indicate the contents and, where applicable, the direction of flow.

(48)

2. Chapter 3: Premises and Equipment

PIC/S does not specify criteria or

numerical for premises and equipment, Your ingenuity will be everything.

Summary of this Chapter:

Premises

design + engineering

Expertise in all stages from design concept to production

Production area

Classified area & zoning

Flow & anti-cross-contamination

QC laboratory

Storage area

(49)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Todayʼs Topics

1. A Quick Recap of Our Previous

Session

2. PIC/S Part I - Chapter 3 Premises

and Equipment

(50)

Good documentation constitutes an essential part of the quality assurance system and is

key to operating in compliance with GMP requirements. The various types of documents

and media used should be fully defined in the manufacturer's Quality Management

System. Documentation may exist in a variety of forms, including paper-based, electronic or photographic media. The main objective of the system of documentation utilised must

be to establish, control, monitor and record all activities which directly or indirectly impact

on all aspects of the quality of medicinal products. The Quality Management System

should include sufficient instructional detail to facilitate a common understanding of the requirements, in addition to providing for sufficient recording of the various processes and evaluation of any observations, so that ongoing application of the requirements may be demonstrated.There are two primary types of documentation used to manage and record GMP compliance: instructions (directions, requirements) and records/reports. Appropriate good documentation practice should be applied with respect to the type of

document.Suitable controls should be implemented to ensure the accuracy, integrity,

availability and legibility of documents. Instruction documents should be free from errors

and available in writing. The term ‘written’ means recorded, or documented on media from which data may be rendered in a human readable form.

.

3. Chapter 4: Documentation

(51)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

3. Chapter 4: Documentation

Documentation is the material that provides official information or evidence or that serves as a record.

Documentation is the process of classifying and annotating texts, photographs, etc.

What is documentation?

Mate ial

P o ess

Do u e tatio

Offi ial  i fo atio  

App o ed & dated

Regula l   e ie ed

Re isio    o t ol

(52)

3. Chapter 4: Documentation

Unlike other industrial products, you cannot test each finished drug on your production line end.

All concepts of GMP, SOP and Validation have been

introduced to address the issues on drug manufacturing.

Notably, all these concepts are based on documentation and by documentation.

Why documentation is essential?

GMP

G

et

M

ore

P

aper

But, pape   eall  does  atte

The truth about GMP

(53)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

3. Chapter 4: Documentation

For example: FDA Inspection Observation Summaries by frequency

Cited ef. # Sho t des iptio Lo g des iptio FY FY FY

 CFR  . d P o edu es  ot i  iti g, full  follo ed The  espo si ilities a d p o edu es appli a le to the  ualit   o t ol u it a e  ot [i   iti g] [full   follo ed].  Spe ifi all , ***

 CFR  . I estigatio s of dis epa ies, failu es

The e is a failu e to tho oughl   e ie  [a  

u e plai ed dis epa ] [the failu e of a  at h o   a  of its  o po e ts to  eet a  of its  a d p o ess  o t ols desig ed to assu e that the  d ug p odu ts ha e the ide tit , st e gth,  ualit ,  a d pu it  the  pu po t o  a e  ep ese ted to  possess.  Spe ifi all , ***

 CFR 

. S ie tifi all  sou d la o ato   o t ols

La o ato   o t ols do  ot i lude the  esta lish e t of s ie tifi all  sou d a d 

app op iate [spe ifi atio s] [sta da ds] [sa pli g  pla s] [test p o edu es] desig ed to assu e that  [ o po e ts] [d ug p odu t  o tai e s] [ losu es]  [i ‐p o ess  ate ials] [la eli g] [d ug p odu ts] 

o fo  to app op iate sta da ds of ide tit ,  st e gth,  ualit  a d pu it .  Spe ifi all , ***

Procedures not in writing, fully followed  

(54)

3. Chapter 4: Documentation

Good documentation constitutes an essential part QAS.

It is key to operating in compliance with GMP

requirements.

Types of documents should be fully defined in QMS.

To establish, control, monitor and record all activities which directly or indirectly impact on the quality of products.

There are two types of documentation used to manage and record GMP compliance: instructions and

records/reports.

Suitable controls should be implemented to ensure the accuracy, integrity, availability

and legibility of documents.

Six key points for documentation

Ele t o i   ase data ase dataPape  

Ele t o i   ase data ase dataPape  

(55)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

3. Chapter 4: Documentation

Required GMP documentation (two primary types)

Site Master File

Specifications Manufacturing Formulae

Processing

Instructions Procedures Packaging/

Testing Instructions

Protocols

Records

Certificates of Analysis Reports

Instruction type

Record/Report type

(56)

3. Chapter 4: Documentation

Definitions of each material:

Instructions type:

Specifications: Describe in detail the requirements with which the products or materials have to conform as a basis for quality evaluation.

Manufacturing Formulae, Processing, Packaging and Testing Instructions:

In detail all the starting materials, equipment and all processing, packaging, sampling and testing instructions.

Procedures: Also known as SOPs, give directions for performing certain operations.

Protocols: Give instructions for performing and recording certain discreet operations.

Record/Report type:

Records: Provide evidence of various actions taken to demonstrate compliance with instructions .

Certificates of Analysis:

Provide a summary of testing results together with the evaluation of compliance to a stated specification.

(57)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

KindGofGDocumentGinGPIC/SGGMP SectionG4 PIC/S GMP Part I

1. QMS

Site Master File

Instruction type

(58)

All types of document should be defined and adhered to. The requirements apply equally to all forms of document media types. Complex systems need to be understood, well documented, validated, and adequate controls should be in place. Many documents (instructions and/or records) may exist in hybrid forms, i.e. some elements as electronic and others as paper based. Relationships and

control measures for master documents, official copies, data handling and records need to be stated for both hybrid and homogenous systems.

Appropriate controls for electronic documents such as templates, forms, and master documents should be implemented. Appropriate controls should be in place to ensure the integrity of the record throughout the retention period.

.

3. Chapter 4: Documentation

GENERATION AND CONTROL OF DOCUMENTATION

Y

a

a

a

a

,

a

y

a

a

y

a

(59)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

Documents containing instructions should be approved, signed and dated by

appropriate and authorised persons. Documents should have unambiguous

contents and be uniquely identifiable. The effective date should be defined.

.

3. Chapter 4: Documentation

GENERATION AND CONTROL OF DOCUMENTATION

Documents containing instructions should be laid out in an orderly fashion and be easy to check. The style and language of documents should fit with their intended use. Standard Operating Procedures, Work Instructions and Methods should be written in an imperative mandatory style.

Documents should not be hand-written; although, where documents require the

entry of data, sufficient space should be provided for such entries.

(60)

Handwritten entries should be made in clear, legible, indelible way.

.

3. Chapter 4: Documentation

GOOD DOCUMENTATION PRACTICES

Any alteration made to the entry on a document should be signed and dated; the alteration should permit the reading of the original information. Where appropriate, the reason for the alteration should be recorded.

(61)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

3. Chapter 4: Documentation

Generation and control of documentation

Define the document type and adhere to it. Electronic base vs. Paper base

Master documents vs. Official copies Comply with the relevant parts of;

Product Specification Files

Manufacturing and Pre-Market Authorization

PSF

MA

PMA

Ele t o i  

ase data ase dataPape  

Maste  

file Offi ial op

I st u tio s Re o ds

Be approved and regularly reviewed  Lay out in an orderly fashion

(62)

3. Chapter 4: Documentation

Good documentation practice

Be clear, legible, indelible for hand-writing

Records to made completed at the time each action is taken and in such a way that all significant activities are traceable. Alteration made to the entry on a document to be signed and

dated; and to permit the reading of the original information.

Re o d

Sig  ; S.Taha a

(63)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

3. Chapter 4: Documentation

Retention of documents

Retention period

Batch documentation must be kept for 1 year after expiry of the batch, or at least 5 years after the batch release, whichever is the longer.

For investigational drugs, the batch documentation must be kept for at least 5 years after the last clinical trial.

Critical documentation, relating to validation or stability, etc. which supports information in the MA should be retained whilst the MA remains in force.

It is acceptable to retire certain documentation if the data has been superseded by a full set of new data, after doing the followings;

document the justification,

consider the requirements for retention of batch documentation.

For example, in the case of Process Validation:

(64)

3. Chapter 4: Documentation

Example of instruction type document

Specifications for starting/packaging materials

a

Des iptio  of the  ate ials

Di e tio s fo  sa pli g a d testi g

Qualitati e a d  ua titati e  e ui e e ts  ith a epta e li its

d

Sto age  o ditio s a d p e autio s

(65)

Cop ight© CM Plus Co po atio . All  ights  ese ed®

3. Chapter 4: Documentation

Example of record type document

Receipt for starting/packaging materials

a

The  a e of the  ate ial o  the deli e   ote;The "i ‐house"  a e a d/o   ode of  ate ial;

Date of  e eipt;

d

Supplie ’s  a e a d  a ufa tu e ’s  a e; 

e

Ma ufa tu e ’s  at h o   efe e e  u e ; 

f

Total  ua tit  a d  u e  of  o tai e s  e ei ed; 

(66)

3. Chapter 4: Documentation

Summary of this Chapter:

Site Master File

Specifications MFG Formulae

Certificates of Analysis Reports

Instructions

Turn your mountains of books into the best

(67)

Thanks

and see you ...

Session 3.

(68)
(69)

Referensi

Dokumen terkait

Menurut analisis ini, wilayah Puncak yang menjadi salah daerah resapan air yang penting, kini telah mengalami masalah besar yakni daya resap air hanya 10 persen

f) Sertifikat keahlian (SKA) dan Ijazah tenaga ahli tetap yang dipersyaratkan, dan.. g) Surat pengangkatan tenaga ahli tetap bersangkutan oleh pimpinan perusahaan dan

[r]

[r]

IGD/I(ota Palu/VIV20l1 tanggal 2 Agustus 2011 oleh Pokja Pengadaan Barang ULP Kota Palu, maka dengan ini diumumkan sebagai berikut

Apabila dari peserta merasa keberatan atas Pengumuman Pelelangan Umum ini, dapat menyampaikan sanggahan secara elektronik melalui aplikasi SPSE kepada POKJA Unit Layanan

BADAN KESATUAN BANGSA DAN POLITIK PEJABAT PENGADAAN BARANG /

diberikan kesempatan untuk mengajukan sanggahan secara tertulis sesuai ketentuan yang ditetapkan dalam PEPRES 54 tahun 2010 dan perubahan terakhir dengan PEPRES 04